OR WAIT null SECS
January 25, 2018
Growth is expected for the generic drugs and biosimilars sectors, driven by cost pressures on healthcare systems.
January 19, 2018
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
January 18, 2018
The company is developing a pipeline of combination therapies using its patented polymer-based matrix delivery system, known as TAOS (targeted orchestrated signalling matrix).
January 16, 2018
The US Government Accountability Office released a report stating that FDA should make its plans to release guidance regarding nonbiological complex drugs public.
January 12, 2018
The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.
January 08, 2018
Graham Reynolds, vice-president and general manager, Global Biologics at West Pharmaceutical Services, Inc., shares insights on key considerations when developing a biologic drug product in a prefilled syringe.
January 05, 2018
The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.
The companies aim to discover and develop locked nucleic acid oligonucleotides as orally available therapies for treating inflammatory bowel diseases.
A single-use DPI from Perlen Packaging, which offers lower-cost production and a more affordable device for emerging markets, won a 2017 CPhI Pharma Award.
January 04, 2018
The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.
